Table 2.
| Study | Train | Test | patient | healthy | MCI | N/A | TP | TN | Method | Acc (%) |
Pre (%) |
Rec (%) |
F1 (%) |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Petrinet | GSE63060 | GSE63060 | 145 | 104 | - | 0 | 145 | 100 |
Pathway + DEGs + Petri net |
98.4 | 97.32 | 100 | 98.64 |
| 2 | Petrinet | GSE63060 | GSE63060 | - | 104 | 80 | 0 | 79 | 102 |
Pathway + DEGs + Petri net |
98.37 | 97.54 | 98.75 | 98.14 |
| 3 | Petrinet | GSE63060 | GSE63060 | 145 | 104 | 80 | 0 | 225 | 81 |
Pathway + DEGs + Petri net |
93.1 | 90.73 | 99.12 | 95.1 |
| 4 | Petrinet | GSE63061 | GSE63061 | 139 | 134 | - | 0 | 137 | 134 |
Pathway + DEGs + Petri net |
99.27 | 100 | 98.57 | 99.28 |
| 5 | Petrinet | GSE63061 | GSE63061 | - | 134 | 109 | 0 | 107 | 133 |
Pathway + DEGs + Petri net |
98.36 | 99.07 | 97.25 | 98.15 |
| 6 | Petrinet | GSE63061 | GSE63061 | 139 | 134 | 109 | 0 | 247 | 104 |
Pathway + DEGs + Petri net |
91.88 | 89.17 | 99.6 | 94.1 |